Differences in clinicopathological characteristics between lipohypertrophy and localized insulin‐derived amyloidosis: A scoping review
Abstract Insulin is used as a therapeutic agent in patients with diabetes, and cutaneous lipohypertrophy (LH) and localized insulin‐derived amyloidosis (LIDA) are well‐known adverse effects associated with insulin injections. The clinical implications, management, assessment methods, and pathologica...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Wiley
2024-03-01
|
| סדרה: | Chronic Diseases and Translational Medicine |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/cdt3.98 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|